Pitfalls of Physician-Directed Treatment of Helicobacter pylori: Results from Two Phase 3 Clinical Trials and Real-World Prescribing Data.

Colin W HowdenKely L SheldonJune S AlmenoffWilliam D Chey

Published in: Digestive diseases and sciences (2021)

Rates of CBT use persist despite sub-optimal eradication rates. Since RHB-105 does not contain clarithromycin, it can be prescribed first-line without concerns about clarithromycin resistance or CYP2C19 status. NCT03198507 & NCT01980095.

Keyphrases

helicobacter pylori
helicobacter pylori infection
primary care
clinical trial
emergency department
electronic health record
big data
machine learning
phase ii
data analysis
open label